Presence of ADAMTS13 activity in a patient with metastatic cancer and thrombotic microangiopathy

Acta Haematol. 2003;109(3):150-2. doi: 10.1159/000069291.

Abstract

Patients with metastatic cancers occasionally present with microangiopathic hemolysis and thrombocytopenia. A patient with metastatic adenocarcinoma of the colon and microangiopathic hemolysis was treated with plasma exchange for a presumptive diagnosis of thrombotic thrombocytopenic purpura (TTP). However, her condition continued to deteriorate and a determination of ADAMTS13 activity revealed that she did not have TTP. Despite similarity in clinical manifestation, microangiopathic hemolysis in patients with metastatic cancers may not be caused by ADAMTS13 deficiency and the role of plasma exchange in such patients should be reevaluated.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • ADAM Proteins
  • ADAMTS13 Protein
  • Adenocarcinoma / blood*
  • Adenocarcinoma / complications*
  • Adenocarcinoma / secondary
  • Aged
  • Colonic Neoplasms
  • Diagnostic Errors
  • Female
  • Hemolysis
  • Humans
  • Metalloendopeptidases / blood*
  • Metalloendopeptidases / deficiency
  • Plasma Exchange / adverse effects
  • Purpura, Thrombotic Thrombocytopenic / diagnosis
  • Purpura, Thrombotic Thrombocytopenic / therapy
  • Thrombosis / blood*
  • Thrombosis / etiology*

Substances

  • ADAM Proteins
  • Metalloendopeptidases
  • ADAMTS13 Protein
  • ADAMTS13 protein, human